Asymptomatic coronary artery disease in ischaemic stroke survivors: A systematic review and meta-analysis

Rahul G Muthalaly1, Timothy B Abrahams1, Nitesh Nerlekar1

  • 1Victorian Heart Institute, Monash University, Clayton, VIC, Australia.

European Stroke Journal
|February 15, 2024
PubMed

Insights

Asymptomatic coronary artery disease (CAD) is prevalent in ischaemic stroke survivors. The presence and severity of this CAD significantly increase the risk of future major adverse cardiovascular events (MACE).

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Epidemiology

Background:

  • Ischaemic stroke and coronary artery disease share common risk factors, leading to a high incidence of cardiac events in stroke survivors.
  • A significant burden of undiagnosed coronary artery disease (CAD) exists among individuals who have experienced ischaemic stroke.

Approach:

  • A systematic review and meta-analysis were conducted following PRISMA guidelines.
  • Included studies focused on acute ischaemic stroke or transient ischaemic attack patients with anatomical coronary artery assessments.
  • Risk of bias was assessed using the Newcastle-Ottawa Scale, with random-effects modeling employed for analyses.

Key Points:

  • The pooled prevalence of any coronary atherosclerosis among ischaemic stroke survivors without known CAD was 66.8%.
  • Obstructive stenosis (>50%) was found in 29.3% of survivors, and high-risk coronary anatomy in 7.0%.
  • The presence of obstructive CAD was associated with an 8-fold increased risk of future major adverse cardiovascular events (MACE).

Conclusions:

  • Asymptomatic coronary artery disease is highly prevalent in ischaemic stroke survivors.
  • The extent and severity of asymptomatic CAD are strongly linked to the risk of future major adverse cardiovascular events.
  • Routine coronary assessment in ischaemic stroke survivors warrants further investigation for potential benefits.
Abstract